Transaction in Own Shares

Summary by AI ^BETAClose X

Essentra plc has purchased a total of 200,000 ordinary shares as part of its ongoing buyback program, with transactions occurring on April 29, May 1, May 5, and May 7, 2026. The weighted average purchase price across these dates was approximately 81.5 to 84.9 pence per share, executed on the London Stock Exchange. These repurchased shares will be held in treasury for potential cancellation or to satisfy employee share plan awards. Following these purchases, the total number of ordinary shares in issue, excluding treasury shares, stands at 284,127,744, which will serve as the denominator for shareholder notification calculations under the FCA's Disclosure and Transparency Rules.

Disclaimer*

Essentra plc

12 May 2026

ESSENTRA PLC

Transaction in Own Shares

Essentra plc ("Essentra", or the "Company") announces that on 29 April and 1, 5 and 7 May 2026 it purchased in 200,000 ordinary shares of 25 pence each in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback programme announced on 29 March 2023 (the "Buyback Programme").

Date	Trading Venue	Volume-weighted average price paid per share (GBp)	Aggregated number of shares purchased	Lowest price paid per share (GBp):	Highest price paid per share (GBp):
29/04/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	81.5000	50,000	81.5000	81.5000
01/05/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	81.6000	50,000	81.6000	81.6000
05/05/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	81.5000	50,000	81.5000	81.5000
07/05/2026	Aquis (AQXE)	-	-	-	-
	BATS (BATE)	-	-	-	-
	Chi-X (CHIX)	-	-	-	-
	Turquoise (TRQX)	-	-	-	-
	London Stock Exchange (XLON)	84.9000	50,000	84.9000	84.9000

The Company intends to hold these shares in Treasury and then either cancel them or retain them for the purpose of satisfying awards under the Company's employee share plans.

Following the settlement of the above purchases, Essentra will have 284 127 744 Ordinary Shares of 25 pence each in issue (excluding 3,077,057 Ordinary Shares of 25 pence each held in treasury).

The figure 284,327,744 will represent the total number of voting rights in Essentra and can be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt LLP as part of the Buyback Programme.

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

For further enquiries, please contact:

Essentra plc

Tim George, Deputy Company Secretary

Tel: +44 (0)1908 359100

Schedule of Purchases - Individual Transactions

Number of shares purchased	Transaction price (Gbp)	Market / Sytematic Internaliser	Date	Time of transaction	Trade ID
50000	81.5	XLON	29/04/2026	15:03:16	00193055358TRLO0
50000	81.6	XLON	01/05	13:58:32	00193160551TRLO0
50000	81.5	XLON	05/05/2026	15:38:46	00193264283TRLO0
50000	84.9	XLON	07/05/2026	12:15:14	00193402671TRLO0

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END